Pay in installments of $6.37 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
GLP 1 drugs may reduce the risk of cancer progressing, study suggests The girls that get itgot it before it sold out , Flatter Me Fiber Pineapple Passion Fruit = doubled GLP 1 levels, zero cravings, clinically backed, and gone for now. Be the first to know when its Weight Loss Patch LIPOGENIX GLP 1 Metabolism Booster Patch (30 Day S GLP 1 receptor agonist based therapies and cardiovascular risk: a review of mechanisms in: Journal of Endocrinology Volume 263 Issue 1 (2024)
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.6 ★★★★★
Based on 23 reviews
Sort
Product Reviews
★★★★★ 5
You wont regret!
Format: Hardcover
Love! Love! LOVE! Everything in one book! Plus you get the e-version included as well! I am in NP school and the differential diagnosis book my school required is a joke! I took a chance on this book and am so glad I did! It's a big book! So plan on leaving it on your desk or tabletop, but at least youll have access to the ebook across your devices
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 11, 2025
★★★★★ 3
Sketchy citations.
Format: Hardcover
Retired MD. Keeping up for the sake of family, friends and myself. I was looking for something like the “Medicine” book I had third year of med school. This is quite a bit more comprehensive. HOWEVER, the references/citations are hopelessly effed up. In the e book chapter on CHF, every reference I checked was about TRANSSEXUALISM in some way!! You authors/editors have some major work to do. I checked other chapters too. Seems even in Cirrhosis chapter the citations are to urology journals, total non sequiturs. HELP!!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 27, 2025
★★★★★ 5
Good resource book
Format: Hardcover
Great book, very informative and does display info in an organized way. Huge book but worth it.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 30, 2025
★★★★★ 5
Well-organised, concise and beautifully illustrated
Format: Hardcover, Format: Hardcover
The book can be described as concise, well-structured (being constant throughout its entirety), and quite graphic, aside from the prestigious drawings from Dr. Frank H. Netter, there's also real-life pictures included.
The online resources are well used, and they're another tool in case someone want's a quick search instead of going to the index.
I recommend this book for anyone who wants to have good knowledge of infectious diseases, without having to go to the more expensive authoritative source (Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases 9th Ed.), which is also mentioned in the preface.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 9, 2024
★★★★★ 5
Excellent reference book!
Format: Hardcover
As with all Netter reference books amazing illustrations and information!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 21, 2024
recommand products
2025 UPDATE – The GLP-1 revolution will shrink orthopedic surgeries
27.72
GLP-1 Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline
22.80
Just how many Americans are taking GLP-1s now
29.80
Management of Nausea Resulting from GLP1 Agonists for T2DM
21.67
The United States GLP-1 Agonists Weight Loss Drugs Market Size & Outlook, 2030
21.64